Maxim Valer

Generium ZAO is a biotechnology company based in Moscow, Russian Federation. The company is a leader in the Russian pharmaceutical market for orphan diseases and has its own R&D park capable of developing any biotech product from molecule design to commercial production. Generium's manufacturing facilities comply with international GMP standards and produce a unique variety of biotech products, including biomedical cell products. The private company offers job opportunities and is dedicated to biotechnological research and development.

Oboronprom United Industrial Corp. JSC operates as a holding company with interests in civilian and military helicopters manufacturing. It operates as a diversified industrial-investment group in the engineering and technologies sectors. The company was founded in 2002 and is headquartered in Moscow, the Russian Federation.

Astor OOO is a Russian company that supplies leather. The private company is based in Blagoveschensk, Russian Federation.

Oncotartis LLC engages in the development of anti-cancer drugs. It develops drugs to treat prostrate and breast cancer, melanoma, leukemia and lymphoma. The company was founded by Alexander Polinsky, Andrei Gudkov, and Olga Chernova in 2011 and is headquartered in Buffalo, NY.

UEC-Kuznetsov PJSC engages in the production and repair of aircraft gas turbine engines and liquid-propellant rocket motors. It offers motors for space launch R-7, drive gas compressor units and modular stations. The company is founded in 1912 and is headquartered in Samara, Russian Federation.

OTCPharm PJSC engages in the production, marketing, promotion and wholesaling of pharmaceutical products. Its product portfolio brands include Arbidol, Pentalgin, Complivit, Flucostat, Aphobasolum, Codelac, Amixin, Acipol, Maxicold, Rinostop, Magnelis B6, Noopept, Asvitol, Ascophen-P, Next, Lactazar, Selmevit, Termicon, Lactonorm, Cyclovita, Cynocap, Univit, Nitrocor, Neosmectin, Klarisens, Azitrox, Gastrozol, Mycoderil. The company was founded on December 23, 2013 and is headquartered in Moscow, Russia.

Constanta Croup LLC specializes in designing, manufacturing, and installing translucent facade systems. The company is based in Nizhny Novgorod, Russian Federation. The Russian company was founded in 2011, and Andrey Georgiyevich Reus has been the CEO of the company since 2013.

UEC-Aviadvigatel JSC is a company based in Perm, Russian Federation. The Russian company specializes in aviation, oil and gas transportation, and energy. UEC-Aviadvigatel JSC is known for their PD-14 engine and a family of advanced engines. UEC-Aviadvigatel JSC also provides operation support for various aircraft, such as the MS-21-310 with PD-14 and the IL-76TD-90VD with PS-90A-76 engines. The company has partnerships with companies like Gazprom Transgaz Volgograd and Lukoil-Western Siberia. The company is ultimately controlled by the Government of Russia. UEC-Aviadvigatel JSC was acquired by Oboronprom United Industrial Corp. JSC from Sistema PJSFC on December 19, 2011.

Russian Helicopters JSC develops, manufactures and sells military and civil helicopters. It includes design bureaus, helicopter assembly plants, components production, maintenance and repair enterprises, aircraft repair plants, and helicopter service companies providing after-sales support in Russia and abroad. The company was founded in 2007 and is headquartered in Moscow, Russia.

Trans Nova Investments Ltd. provides investment services. The company is based in Limassol, Cyprus.

Pharmstandard Ventures (Pharmstd Ventures) is a venture capital subsidiary of Pharmstandard PJSC headquartered in Moscow, Russia. The firm was founded in 2013 by Dr. Andrey Petrov.

Part of Valline Srl, Master Pharma is an Italian pharmaceutical company that manufactures pharmaceutical products. The company is based in Parma, Italy. The company was founded by Aleksandr Mikhailovich Shuster. Master Pharma was acquired by CHIESI Farmaceutici SpA on May 01, 1998.

Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA.

enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada.